Hutchison China MediTech Limited (Chi-Med) is a China-based, globally-focused healthcare group. The Company researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. Its Innovation Platform focuses on discovering and developing therapeutics in oncology and autoimmune diseases for the global market. Its Commercial Platform manufactures markets and distributes prescription drugs and consumer health products in China.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:HCM
- CUSIP: N/A
- Web: N/A
- Market Cap: £1.88 billion
- Outstanding Shares: 60,642,000
- 50 Day Moving Avg: GBX 3,044.57
- 200 Day Moving Avg: GBX 2,490.54
- 52 Week Range: GBX 1,728.80 - GBX 3,335.71
Sales & Book Value:
- Trailing P/E Ratio: 158.16
- P/E Growth: 0.00
- Annual Revenue: £216.08 million
- Price / Sales: 8.70
- Book Value: GBX 3.04 per share
- Price / Book: 10.20
- Average Volume: 14,635 shs.
Frequently Asked Questions for Hutchison China MediTech Limited (LON:HCM)
What is Hutchison China MediTech Limited's stock symbol?
Hutchison China MediTech Limited trades on the London Stock Exchange (LON) under the ticker symbol "HCM."
When will Hutchison China MediTech Limited make its next earnings announcement?
Where is Hutchison China MediTech Limited's stock going? Where will Hutchison China MediTech Limited's stock price be in 2017?
2 brokers have issued twelve-month target prices for Hutchison China MediTech Limited's shares. Their forecasts range from GBX 3,530 to GBX 3,530. On average, they anticipate Hutchison China MediTech Limited's stock price to reach GBX 3,530 in the next year. View Analyst Ratings for Hutchison China MediTech Limited.
Who are some of Hutchison China MediTech Limited's key competitors?
Some companies that are related to Hutchison China MediTech Limited include Aberdeen Asset Management plc (ADN), B&M European Value Retail SA (BME), Inmarsat Plc (ISAT), Intu Properties PLC (INTU), Booker Group Plc (BOK), Inchcape plc (INCH), Bellway plc (BWY), Tate & Lyle PLC (TATE), Hiscox Ltd (HSX), IMI plc (IMI), BBA Aviation plc (BBA), Playtech PLC (PTEC), Iwg Plc (IWG), Spectris plc (SXS), Derwent London Plc (DLN), Phoenix Group Holdings (PHNX), Metro Bank PLC (MTRO) and Howden Joinery Group Plc (HWDN).
How do I buy Hutchison China MediTech Limited stock?
Shares of Hutchison China MediTech Limited and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Hutchison China MediTech Limited stock cost?
One share of Hutchison China MediTech Limited stock can currently be purchased for approximately GBX 3,100.
Earnings History for Hutchison China MediTech Limited (LON:HCM)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Hutchison China MediTech Limited (LON:HCM)
Current Year EPS Consensus Estimate: $-0.21 EPS
Dividend History for Hutchison China MediTech Limited (LON:HCM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Hutchison China MediTech Limited (LON:HCM)Insider Trades by Quarter for Hutchison China MediTech Limited (LON:HCM)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/15/2017||Paul Rutherford Carter||Insider||Buy||2,800||GBX 2,637||£73,836|
|11/21/2016||Michael Howell||Insider||Sell||3,000||GBX 1,890||£56,700|
|10/28/2016||Michael Howell||Insider||Sell||2,500||GBX 1,860||£46,500|
|10/26/2016||Michael Howell||Insider||Sell||3,000||GBX 1,850||£55,500|
|10/25/2016||Michael Howell||Insider||Sell||1,000||GBX 1,840||£18,400|
|10/24/2016||Michael Howell||Insider||Sell||339||GBX 1,825||£6,186.75|
|10/7/2016||Michael Howell||Insider||Sell||15,000||GBX 1,790||£268,500|
|4/21/2015||Christopher Nash||Insider||Buy||1,388||GBX 1,800||£24,984|
|4/15/2015||Simon To||Insider||Buy||28,000||GBX 1,585||£443,800|
|4/10/2015||Simon To||Insider||Buy||25,000||GBX 1,421.50||£355,375|
|4/7/2015||Edith Shih||Insider||Buy||2,000||GBX 1,385||£27,700|
|4/2/2015||Simon To||Insider||Buy||10,000||GBX 1,385||£138,500|
|4/1/2015||Edith Shih||Insider||Buy||15,000||GBX 1,365||£204,750|
|3/30/2015||Edith Shih||Insider||Buy||13,000||GBX 1,300||£169,000|
Headline Trends for Hutchison China MediTech Limited (LON:HCM)
Latest Headlines for Hutchison China MediTech Limited (LON:HCM)
Hutchison China MediTech Limited (HCM) Chart for Saturday, May, 27, 2017